SCHEMBL26889463

SCHEMBL26889463

O=C(O)c1ccc(-c2ccc(C(=O)Nc3cccc4ccccc34)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.77
RAB9A P51151 6/20 0.77
CYP1A2 P05177 1/20 0.77
CYP3A4 P08684 1/20 0.77
CYP2D6 P10635 1/20 0.77
CYP2C9 P11712 1/20 0.77
CYP2C19 P33261 1/20 0.77
POLB P06746 1/20 0.65
HSD17B10 Q99714 1/20 0.64
KMT2A Q03164 3/20 0.63
DHODH Q02127 1/20 0.59
CHRNB2 P17787 1/20 0.57
CHRNB4 P30926 1/20 0.57
CHRNA3 P32297 1/20 0.57
CHRNA4 P43681 1/20 0.57
EGFR P00533 1/20 0.56
ERBB2 P04626 1/20 0.56
TAOK1 Q7L7X3 1/20 0.55
MAPT P10636 3/20 0.55
HPGD P15428 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3659724 0.95 RAB9A (0.84) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL26885232 0.94 NPC1 (0.81) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL26885225 0.90 RAB9A (0.74) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL26885585 0.88 RAB9A (0.77) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL4642544 0.87 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL30184438 0.87 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL26885257 0.87 RAB9A (0.69) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL6797734 0.85 NPC1 (0.68) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL26891627 0.84 NPC1 (0.62) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL27561288 0.83 RAB9A (0.79) NPC1RAB9ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF ACE2, ACE, SARS1 NPC1 72/4885RAB9A 1817/4885CYP1A2 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.